Usability and effectiveness of Suprathel® in partial thickness burns in children

Z M Rashaan1,2, P Krijnen3, J H Allema4

  • 1Department of Surgery, Leiden University Medical Center, PO Box 9600, 2333 ZA, Leiden, The Netherlands. zrashaan@rkz.nl.

Insights

Suprathel® shows promise for pediatric burn treatment, reducing pain and improving scars. However, effective adherence requires extensive wound debridement, particularly with Versajet®.

Area of Science:

  • Regenerative Medicine
  • Pediatric Burn Care
  • Wound Healing Technologies

Background:

  • Partial thickness burns in children present unique challenges in wound management.
  • Optimizing treatment for pediatric burns is crucial to minimize pain, infection, and long-term scarring.
  • Advanced wound dressings aim to improve healing outcomes and patient comfort.

Purpose of the Study:

  • To evaluate the usability and effectiveness of Suprathel® in treating partial thickness burns in pediatric patients.
  • To assess key parameters including adherence, reepithelialization, pain, and scar formation.

Main Methods:

  • A prospective, observational study was conducted.
  • Evaluated adherence, reepithelialization time, grafting needs, wound colonization, pain scores (VAS and COMFORT-B), dressing changes, hospital stay, and scar formation (POSAS).
  • Suprathel® adherence was specifically assessed in relation to Versajet® debridement.

Main Results:

  • Suprathel® adherence was observed only in wounds debrided with Versajet®.
  • Median reepithelialization time was 13 days; 3 patients required split-skin grafting.
  • Pain scores were manageable, and scar assessment scores were favorable at 3 and 6 months post-burn.

Conclusions:

  • Suprathel® demonstrates potential benefits in reducing pain and improving scar outcomes for pediatric burn patients.
  • Adequate adherence of Suprathel® is contingent upon thorough wound debridement, preferably with Versajet®.
  • Further research may optimize its application in pediatric burn management.
Abstract